The strengths and limitations of meta-analyses based on aggregate data
Open Access
- 25 April 2005
- journal article
- research article
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 5 (1) , 14
- https://doi.org/10.1186/1471-2288-5-14
Abstract
Properly performed systematic reviews and meta-analyses are thought by many to represent among the highest level of evidence addressing important clinical issues. Few would disagree that meta-analyses based on individual patient data (IPD) offer several advantages and represent the standard to which all other systematic reviews should be compared. All cancer-related meta-analyses cited in Medline were classified as based on aggregate or individual patient data. A review was then undertaken of all reports comparing the comparative strengths and limitations of meta-analyses using either aggregate or individual patient data. The majority of published meta-analyses are based on summary or aggregate patient data (APD). Reasons suggested for this include the considerable resources, years of study and often, broad international cooperation required for IPD meta-analyses. Many of the most important features of systematic reviews including formal meta-analyses are addressed by both IPD and APD meta-analyses. The need for defining an explicit and relevant clinical question, exhaustively searching for the totality of evidence, meticulous and unbiased data transfer or extraction, assessment of between study heterogeneity and the use of appropriate statistical methods for estimating summary effect measures are essentially the same for the two approaches. IPD offers advantages and, when feasible, should be considered the best opportunity to summarize the results of multiple studies. However, the resources, time and cooperation required for such studies will continue to limit their use in many important areas of clinical medicine which can be meaningfully and cost-effectively approached by properly performed APD meta-analyses. APD meta-analyses continue to be the mainstay of systematic reviews utilized by the US Preventive Services Task Force, the Cochrane Collaboration and many professional societies to support clinical practice guidelines.Keywords
This publication has 22 references indexed in Scilit:
- Meta-Analyses Based on Abstracted Data: A Step in the Right Direction, but Only a First StepJournal of Clinical Oncology, 2004
- Meta-analysis of published studies or meta-analysis of individual data? Caesarean section in HIV-positive women as a study casePublic Health, 2003
- To IPD or not to IPD?Evaluation & the Health Professions, 2002
- Individual patient‐ versus group‐level data meta‐regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly headStatistics in Medicine, 2002
- Individual Patient- versus Literature-Based Meta-analysis of Survival Data: Time to Event and Event Rate at a Particular Time Can Make a Difference, an Example Based on Head and Neck CancerControlled Clinical Trials, 2001
- The Value of the Aggregate Data Approach in Meta-Analysis with Time-to-Event OutcomesJournal of the Royal Statistical Society Series A: Statistics in Society, 2001
- An Assessment of Methods to Combine Published Survival CurvesMedical Decision Making, 2000
- Recursive Cumulative Meta-analysis: A Diagnostic for the Evolution of Total Randomized Evidence from Group and Individual Patient DataJournal of Clinical Epidemiology, 1999
- From science to practice. Meta-analyses using individual patient data are neededJAMA, 1995
- Meta-analysis of the literature or of individual patient data: is there a difference?The Lancet, 1993